Riskpilot← Back to searchSign inGet full accessHadel Anwar Gynverksamhet AB
ABActiveOrg 5569244089Sandstuguvägen 11Medical specialists activities · NACE 8622Est. 20130 employees
Revenue 2025
SEK 0
EBITDA margin
—
-26% vs 2024
Equity ratio
86.8%
Financial strength
Net profit 2025
SEK -177K
-756% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -23K | -26% |
| Net profit | SEK -177K | -756% |
| Total assets | SEK 3,9M | -3% |
| Equity | SEK 3,3M | -10% |
| Employees | 0 | — |
Legal name
Hadel Anwar Gynverksamhet AB
Org number
5569244089
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
1 mars 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Gynekologisk undersökning, utredning, diagnostik, behandling och uppföljning av patienter med gynekologiska sjukdomstillstånd och besvär, uppföljning av patienter som behandlats för gynekologisk cancer, fertilitetsutredning.
Address
Sandstuguvägen 11
Email
hadelanwar@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 129 | 49 | 0 | 0 |
| Staff expenses | — | −0 | −0 | −0 | −0 |
| EBITDA | −91 | 86 | 10 | −18 | −23 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −91 | 86 | 10 | −18 | −23 |
| Net financials | 2 231 | 1 730 | 1 523 | −843 | 0 |
| Profit before tax | 1 605 | 1 361 | 1 533 | −19 | −23 |
| Tax | −329 | −283 | −322 | −1 | −154 |
| Net profit | 1 276 | 1 077 | 1 211 | −21 | −177 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 523 | 4 564 | 5 027 | 3 983 | 3 852 |
| Equity | 2 183 | 2 960 | 3 956 | 3 731 | 3 345 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 768 | 577 | 43 | 67 | 322 |
| Total debt | 768 | 577 | 43 | 67 | 322 |
EBITDA margin
-2336500.0%
This company
15.8%
Market median
-14788075% vs market
20212025
Equity ratio
86.8%
This company
38.2%
Market median
+127% vs market
20212025
Return on equity
-5.3%
This company
18.4%
Market median
-129% vs market
20212025
Net profit margin
-17685900.0%
This company
8.1%
Market median
-218344544% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hadel Anwar Gynverksamhet AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Moayad Al-Azzawy | Deputy Board Member | 0 companies |
| Hadel Anwar Jamel | Board of Directors | 0 companies |